Comera Life Sciences Holdings, Inc. (CMRA)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Aug 6, 2025
Comera Life Sciences Holdings Company Description
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform.
Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions.
The company’s lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis.
Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
Comera Life Sciences Holdings, Inc.
| Country | United States |
| Founded | 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 13 |
| CEO | Michael Campbell |
Contact Details
Address: 12 Gill Street Woburn, Delaware 01801 United States | |
| Phone | 617 871 2101 |
| Website | comeralifesciences.com |
Stock Details
| Ticker Symbol | CMRA |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US20037C1080 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Michael G. Campbell CPA | Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer |
| Dr. David Soane Ph.D. | Co-Founder and Member of Scientific Advisory Board |
| Janice Marie McCourt B.S., CLP, M.B.A., R.Ph. | Chief Business Officer |